Cybin Inc. Common Stock
Status: Publicly traded
Direct answer
Cybin Inc. Common Stock is publicly traded on NASDAQ under the ticker HELP.
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Can you invest in Cybin Inc. Common Stock?
Yes. Cybin Inc. Common Stock trades publicly on NASDAQ as HELP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cybin Inc. Common Stock
Detailed equity research is provided by MarketSnap.